Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

$80 billion drug merger talks back on

Article Abstract:

Glaxo Wellcome PLC and SmithKline Beecham PLC are in renewed negotiations regarding their merger. The acquistion of SmithKline by Glaxo will create the largest pharmaceutical company in the world, overtaking Merck and Company Inc. Under the meger terms, Glaxo shareholders will own 60% of the new company, while SmithKline shareholders will own 40%. The transaction, which could be announced as early as Jan 17, 2000, is valued at $80 million.

Author: Valdmanis, Thor
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
SmithKline Beecham PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drug merger turns into tense triangle

Article Abstract:

Warner-Lambert Co and Pfizer Inc is holding talks on a possible merger. A decision by Warner-Lambert to merge with Pfizer will be detrimental to American Home Products Corp (AHP), which was the first to propose a merger with Warner-Lambert. Warner-Lambert is being pressured by its shareholders to consider Pfizer's stock offer of $92.18 per share, which is significantly larger than AHP's offer of $63.59 per share.

Author: Valdmanis, Thor
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
Warner-Lambert Co.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drug firms polish merger

Article Abstract:

The merger between Glaxo Wellcome and SmithKline Beecham is expected to create the world's biggest pharmaceutical company with a market value of $180 billion and 7% share in the global prescription drug market. The combined firm, which would dislodge Merck as the world's largest drug firm, would have annual sales of $27 billion with 105,000 employees. Every SmithKline share would be paid with 0.48 Glaxo share, giving Glaxo a 58% stake in the new company and SmithKline, 42%.

Author: Valdmanis, Thor
Publisher: USA Today
Publication Name: USA Today
Subject: News, opinion and commentary
ISSN: 0734-7456
Year: 2000
Foreign operations, Drugs, Glaxo Wellcome PLC, SmithKline Beecham

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United Kingdom, United States
Similar abstracts:
  • Abstracts: Manulife may need to put cash into venture with troubled partner. Indonesia warned in Manulife case
  • Abstracts: The Monday interview: Lucas has prescription for drug firm mergers. Quebec's drug payment policy hasn't stopped job losses: study
  • Abstracts: E-trader lets investors trade Nasdaq stocks in penny increments. Investors wary of GE-Honeywell
  • Abstracts: Buick makes Rendezvous to break into truck market. Automakers go for size, power, style in new SUVs
  • Abstracts: Airlines offer double miles to attract fliers. Fliers' dream: elbowroom. Fliers want calls if flight canceled
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.